Effect of Administering Short-Course, Standardized Regimens in Individuals Infected with Drug-Resistant Mycobacterium tuberculosis Strains

被引：0

作者：

J. J. Furin

M. C. Becerra

S. S. Shin

J. Y. Kim

J. Bayona

P. E. Farmer

机构：

[1] Department of Social Medicine,

[2] Harvard Medical School,undefined

[3] 641 Huntington Avenue,undefined

[4] Boston,undefined

[5] MA 02115,undefined

[6] USA e-mail: JENFURIN@AOL.COM,undefined

[7] Department of Epidemiology,undefined

[8] Harvard School of Public Health,undefined

[9] Boston,undefined

[10] MA,undefined

[11] USA,undefined

[12] Socios En Salud,undefined

[13] Sucursal,undefined

[14] Lima,undefined

[15] Peru,undefined

来源：

European Journal of Clinical Microbiology and Infectious Diseases | 2000年 / 19卷

关键词：

Tuberculosis; Standard Treatment; Mycobacterium Tuberculosis; Standard Regimen; Susceptibility Pattern;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Presented here are the cases of three siblings with multidrug-resistant tuberculosis who demonstrated increased antituberculous-drug resistance during the periods in which they received standard regimens of directly observed, short-course chemotherapy that were administered before the susceptibility patterns of their Mycobacterium tuberculosis isolates had been checked. More specifically, they acquired resistance to drugs they received as part of ineffective standard treatment and retreatment regimens. Development of antituberculous-drug resistance through inadvertent, inadequate therapy appears to be the most likely explanation for the increased resistance seen in these three patients.

引用

页码：132 / 136

页数：4

共 50 条

[41] 24-locus MIRU-VNTR and Spoligotyping analysis of drug-resistant Mycobacterium tuberculosis strains isolated from Northeastern Thailand
Rueangsak, Kulrattana
Tanuchit, Sonvanee
Chumpol, Jaluporn
Kamhorm, Sawian
Ngoenpramual, Montira
Namwat, Wises
Faksri, Kiatichai
Wilailuckana, Chotechana
Pinlaor, Porntip
Sangka, Arunnee
INFECTION GENETICS AND EVOLUTION, 2020, 85
[42] Implementation of the 'Removed Injectable modified Short-course regimens for EXpert Multidrug Resistant Tuberculosis' (RISE study) in Tanzania: a protocol for a mixed-methods process evaluation
Kalolo, Albino
Lalashowi, Julieth
Pamba, Doreen
Shayo, Pendomartha Joseph
Gitige, Catherine
Mvungi, Happiness
Ntagazwa, Webhale
Lekule, Isaac
Kisonga, Riziki
Mleoh, Liberate
John, Johnson
Kapologwe, Ntuli A.
Mutayoba, Beatrice
Matechi, Emmanuel
Mpagama, Stellah G.
Ntinginya, Nyanda Elias
BMJ OPEN, 2022, 12 (05):
[43] Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis
Naidoo, C. C.
Pillay, M.
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (06) : O361 - O369
[44] Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis
Gao, Jingtao
Ma, Yan
Du, Jian
Zhu, Guofeng
Tan, Shouyong
Fu, Yanyong
Ma, Liping
Zhang, Lianying
Liu, Feiying
Hu, Daiyu
Zhang, Yanling
Li, Xiangqun
Li, Liang
Li, Qi
BMC PULMONARY MEDICINE, 2016, 16
[45] Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis
Jingtao Gao
Yan Ma
Jian Du
Guofeng Zhu
Shouyong Tan
Yanyong Fu
Liping Ma
Lianying Zhang
Feiying Liu
Daiyu Hu
Yanling Zhang
Xiangqun Li
Liang Li
Qi Li
BMC Pulmonary Medicine, 16
[46] Drug susceptibility pattern of Mycobacterium tuberculosis isolates from patients of Category-II failure of pulmonary tuberculosis under directly observed treatment short-course from north India
Prasad, Rajendra
Verma, Sanjay Kumar
Garg, Rajiv
Jain, Amita
Anand, Suneesh C.
Hosmane, Giridhar Belur
Verma, Rajendra Kumar
Kushwaha, Narendra Singh
Kant, Surya
BIOSCIENCE TRENDS, 2012, 6 (03) : 110 - 114
[47] Biological Evaluation of Potent Triclosan-Derived Inhibitors of the Enoyl-Acyl Carrier Protein Reductase InhA in Drug-Sensitive and Drug-Resistant Strains of Mycobacterium tuberculosis
Stec, Jozef
Vilcheze, Catherine
Lun, Shichun
Perryman, Alexander L.
Wang, Xin
Freundlich, Joel S.
Bishai, William
Jacobs, William R., Jr.
Kozikowski, Alan P.
CHEMMEDCHEM, 2014, 9 (11) : 2528 - 2537
[48] Fitness-compensatory mutations facilitate the spread of drug-resistant F15/LAM4/KZN and F28 Mycobacterium tuberculosis strains in KwaZulu-Natal, South Africa
Naidoo, Charissa C.
Pillay, Manormoney
JOURNAL OF GENETICS, 2017, 96 (04) : 599 - 612
[49] In Vitro Antimycobacterial Activity of Human Lactoferrin-Derived Peptide, D-hLF 1-11, against Susceptible and Drug-Resistant Mycobacterium tuberculosis and Its Synergistic Effect with Rifampicin
Intorasoot, Sorasak
Intorasoot, Amornrat
Tawteamwong, Arocha
Butr-Indr, Bordin
Phunpae, Ponrut
Tharinjaroen, Chayada Sitthidet
Wattananandkul, Usanee
Sangboonruang, Sirikwan
Khantipongse, Jiaranai
ANTIBIOTICS-BASEL, 2022, 11 (12):
[50] Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial
Rangaka, Molebogeng X.
Hamada, Yohhei
Duong, Trinh
Bern, Henry
Calvert, Joanna
Francis, Marie
Clarke, Amy Louise
Ghanouni, Alex
Layton, Charlotte
Hack, Vanessa
Owen-Powell, Ellen
Surey, Julian
Sanders, Karen
Booth, Helen L.
Crook, Angela
Griffiths, Chris
Horne, Robert
Kunst, Heinke
Lipman, Marc
Mandelbaum, Mike
White, Peter J.
Zenner, Dominik
Abubakar, Ibrahim
BMJ OPEN, 2022, 12 (09):

← 1 2 3 4 5 →